Deployment Information - The National Center for Medical Intelligence and CDC assess that EVD represents a low risk to DoD personnel and the U.S. general public. The overwhelming majority of tasks U.S. military personnel will be performing in West Africa should not put them at risk of becoming infected with Ebola virus.
Other products are available on the
APHC Health Information Products eCatalog. Suggested filter category: Deployment Health.
Ebola: What You Need to Know Video
To download: Right click and "Save target as"
Windows Media file
West Africa Medical Threat Briefing
AKO - (restricted access)
24/7 EVD Information Line:
CONUS 800-984-8523, DSN 421-3700
OCONUS DSN 312-421-3700
U.S. Army Medical Research
Institute of Infectious Diseases
Emergency Response Line:
Military Treatment Facilities
- Ebola symptoms can start 2 to 21 days after becoming infected with the virus, but typically symptoms begin in 8-10 days. The most common symptoms of Ebola infection are fever, tiredness, loss of appetite, vomiting, diarrhea, headache and stomach pain.
- Persons presenting with a subjective fever or a temperature of ≥100.4°F (≥38°C) and other symptoms compatible with Ebola, such as headache, muscle pain, weakness, diarrhea, vomiting, abdominal (stomach) pain or unexplained bleeding or bruising should be asked about recent travel and exposure to persons with Ebola.
- Evaluation should also include work-up for more common travel-related illnesses, such as malaria, influenza and other febrile diseases.
- CDC: Emergency Preparedness and Response - Health Alert Network Message,
HAN 381 - Clinical Considerations for the Evaluation of Ill Travelers from Liberia to the United States
Emergency Preparedness and Response - Health Alert Network Messages – 2014
- CDC: Emergency Prepared and Response - Guidelines for Evaluation of U.S. Patients Suspected of Having Ebola Virus Disease
- DoD (AFHSC):
Detecting and Reporting DoD Cases of Ebola Virus Disease Infection: Guidance as of 17 OCT 2014
Ebola Virus Disease Screening Questionnaire Template (updated 11/9/14) If asked for a password, select Cancel each time and the document will open. Note that the popup window may be under this screen.
DD Form 2990 - Ebola Virus Disease Exposure Risk Evaluation (In Theater Use Only)
GENADMIN Message 15-01 (Guidance for Healthcare Personnel Evaluating Patients with Suspected Ebola Virus Disease (EVD))
(AKO - restricted access)
- Control of Communicable Diseases Manual: APHA's
Ebola-Marburg virus chapter is available free of charge
Detailed Hospital Checklist for Ebola Preparedness
Treatment - There is no vaccination or specific treatment for EVD. Intensive supportive care is required to maintain fluid and electrolyte balance, oxygen status and blood pressure, and respond to complications. Outbreaks may have case fatality rates (CFR) as high as 90%, but some treatment centers in the current outbreak are reporting CFR of 35% or less.
- Ebola virus spreads from person to person by direct contact with blood, secretions, organs or other bodily fluids (such as sweat, vomit, and diarrhea) of infected people. Only people who have symptoms of EVD, or have recently died from EVD, can transmit the virus to others. The risk of spreading the infection to others increases as the disease progresses. CDC guidance for U.S. care settings includes initiating standard, contact and droplet precautions for suspected EVD.
- Report suspected EVD cases to the APHC Disease Epidemiology Program telephonically at (410) 417-2377 or (800) 222-9698
- Report suspected EVD cases as Viral Hemorrhagic Fever in
- Inform the local health department
Laboratory Testing - MTFs must ensure clinical Ebola specimen submission and testing on patients is coordinated with the MTF lab, MTF Preventive Medicine Department and the state/ local public health department.